Bender Robert & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.9M | Sell |
|
|||||
|
2025
Q2 | $14.3M | Sell |
|
|||||
|
2025
Q1 | $15.2M | Buy |
|
|||||
|
2024
Q4 | $14.1M | Buy |
|
|||||
|
2024
Q3 | $16M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $15.1M | Sell |
|
|||||
|
2023
Q4 | $11.5M | Buy |
|
|||||
|
2023
Q3 | $10.6M | Buy |
|
|||||
|
2023
Q2 | $9.27M | Buy |
|
|||||
|
2023
Q1 | $3.83M | Buy |
|
|||||
|
2022
Q4 | $4.04M | Buy |
|
|||||
|
2022
Q3 | $3.54M | Buy |
|
|||||
|
2022
Q2 | $3.31M | Buy |
|
|||||
|
2022
Q1 | $2.87M | Buy |
|
|||||
|
2021
Q4 | $2.09M | Hold |
|
|||||
|
2021
Q3 | $2.09M | Buy |
|
|||||
|
2021
Q2 | $2.08M | Buy |
|
|||||
|
2021
Q1 | $1.51M | Buy |
|
|||||
|
2020
Q4 | $1.24M | Buy |
|
|||||
|
2020
Q3 | $961K | Buy |
|
|||||
|
2020
Q2 | $1.03M | Buy |
|
|||||
|
2020
Q1 | $757K | Hold |
|
|||||
|
2019
Q4 | $717K | Sell |
|
|||||
|
2019
Q3 | $623K | Hold |
|
|||||
|
2019
Q2 | $603K | Sell |
|
|||||
|
2019
Q1 | $739K | Buy |
|
|||||
|
2018
Q4 | $644K | Buy |
|
|||||
|
2018
Q3 | $595K | Sell |
|
|||||
|
2018
Q2 | $487K | Sell |
|
|||||
|
2018
Q1 | $450K | Sell |
|
|||||
|
2017
Q4 | $500K | Sell |
|
|||||
|
2017
Q3 | $519K | Buy |
|
|||||
|
2017
Q2 | $496K | Sell |
|
|||||
|
2017
Q1 | $535K | Sell |
|
|||||
|
2016
Q4 | $477K | Buy |
|
|||||
|
2016
Q3 | $507K | Buy |
|
|||||
|
2016
Q2 | $490K | Sell |
|
|||||
|
2016
Q1 | $474K | Buy |
|
|||||
|
2015
Q4 | $525K | Buy |
|
|||||
|
2015
Q3 | $473K | Sell |
|
|||||
|
2015
Q2 | $466K | Buy |
|
|||||
|
2015
Q1 | $288K | Buy |
|
|||||
|
2014
Q4 | $341K | Buy |
|
|||||
|
2014
Q3 | $300K | Sell |
|
|||||
|
2014
Q2 | $292K | Sell |
|
|||||
|
2014
Q1 | $280 | Buy |
|
|||||
|
2013
Q4 | $241K | Buy |
|
|||||
|
2013
Q3 | $233K | Buy |
|
|||||
|
2013
Q2 | $220K | Buy |
|